AKT1 and acute myeloid leukemia: Similarly, when FLT3–ITD mutant human AML cells lines (MOLM-14, PL-21, and MV4-11) were exposed to palbociclib, the level of AURK and AKT messenger RNA was significantly decreased in a dose-dependent manner at clinically relevant concentrations.